FR901228. Antineoplastic antibiotic

Drugs of the Future

Volumn 24, Issue 11, 1999, Pages 1184-1188

  Wang, Hwa Chain R ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYLIDENE 4,21 DIISOPROPYL 2 OXA 12,13 DITHIA 5,8,20,23 TETRAAZABICYCLO[8.7.6]TRICOS 16 ENE 3,6,9,19,22 PENTONE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; FR 901228; HISTONE DEACETYLASE; N (3 HYDROXY 7 SULFANYL 4 HEPTENOYL) D VALYL D CYSTEINYL 2 AMINO 2 BUTENOYL L VALINYL(4-1)LACTONE CYCLIC[1,2]DISULFIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BACTERIUM ISOLATE; CHROMOBACTERIUM; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE RAS; RAT; REVIEW;

EID: 0033385967     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1999.024.11.885479     Document Type: Review

References (18)

1. Li, K.W., Wu, J., Xing, W., Simon, J.A. Total synthesis of the antitumor depsipeptide FR901228. J Am Chem Soc 1996, 118: 7237-8.
2. Ueda, H., Nakajima, H., Hori, Y., Fujita, T., Nishimura, M., Goto, T., Okuhara, M. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromabacterium violaceum No. 968: I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J Antibiot 1994, 47: 301-10.
3. Ueda, H., Nakajima, H., Hori, Y., Goto, T., Okuhara, M. Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromabacterium violaceum No. 968, on Ha-ras transformed NIH3T3 cells. Biosci Biotech Biochem 1994, 58:1579-83.
4. Cerutti, P., Hussain, P., Pourzand, C., Aguilst, F. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene. Cancer Res 1994, 54(Suppl.): 1934-8S.
5. Spaargaren, M., Bischoff, J.R., McCormick, F. Signal transduction by Ras-like GTPases: A potential target for anticancer drugs. Gene Expr 1995, 4: 345-56.
6. Rajgolikar, G., Chan, K.K., Wang, H-C.R. Effects of a novel antitumor depsipeptide FR901288 on human breast cancer cells. Breast Cancer Res Treat 1998, 51: 29-38.
7. Nakajima, H., Kim, Y.B., Terano, H., Yoshida, M., Horinouchi, S. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp Cell Res 1998, 241: 126-33.
8. Ueda, H., Manda, T., Matsumoto, S., Nishigaki, F., Kawamura, I., Shimomura, K. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromabacterium violaceum No. 968: III. Antitumor activities on experimental tumors in mice. J Antibiot 1994, 47: 315-23.
9. Byrd, J.C., Shinn, C., Ravi, R., Willis, C.R., Waselenko, J.K., Flinn, I.W., Dawson, N.A., Grever, M.R. Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells. Blood 1999, 94: 1401-8.
10. Yoshida, M., Horinouchi, S., Beppu, T. Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 1995, 17: 423-30.
11. Wang, R., Brunner, T., Zharg, L., Shi, Y. Fungal metabolite FR901228 inhibits c-myc and Fas ligand expression. Oncogene 1998, 17: 1503-8.
12. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z., Hancock, D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992, 69: 119-28.
13. Shi, Y., Glynn, J.M., Guilbert, L.J., Cotter, T.G., Bissonnette, R.P., Green, D.R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 1992, 257: 212-4.
14. Janicke, R.U., Lee, F.H., Porter, A.G. Nuclear c-myc plays an important role in the cytotoxicity of tumor necrosis factor α in tumor cells. Mol Cell Biol 1994, 14: 5661-70.
15. Klefstrom, J., Vastrik, I., Saksela, E., Valle, J., Eilers, M., Alitalo, K. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-α. EMBO J 1994, 13: 5442-50.
16. Walker, P.R., Saas, P., Dietrich, P.Y. Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back. J Immunol 1997, 158: 4521-4.
17. Solary, E., Micheau, O., Dimanche-Boitrel, M.T., Martin, F. The Fas/Fas-ligand system: Implications in the antitumor immune response and in the activity of cytotoxic agents. Bull Cancer 1998, 85: 685-94.
18. Chan, K.K., Bakhtiar, R., Jiang, C. Depsipeptide (FR901228, NSC-630176) pharmacokinetics in the rat by LC/MS/MS. Invest New Drugs 1997, 15: 195-206.